INSTITUTE FOR IN VITRO SCIENCES INC

As filed

Subsection

03

NTEE code

B28

Classification

8400

Street

30 W WATKINS MILL RD STE 100

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Other organizations at this address

1 other organization in the IRS Business Master File lists the same street address. matched by us

This address is a suite or unit (STE 100). Organizations that share one are often clients of the same office-services firm, accountant or registered agent rather than related to each other.

We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.

• AMERICAN SOCIETY FOR CELLULAR AND COMPUTATIONAL TOXICOLOGY INC

  EIN 27-2792207

Mission and programs · 2025

• RESEARCH AND TESTING: IIVS WORKED WITH MORE THAN SIXTY COMPANIES TO DETERMINE THE APPROPRIATE NON-ANIMAL TESTING STRATEGIES, CONDUCT TESTING, AND ASSIST IN INTERPRETATION OF DATA. OVER 880 COMPOUNDS/PRODUCTS WERE TESTED AT THE IIVS LABORATORY - MOSTLY IN MORE THAN ONE TEST. IIVS CONTINUES TO OPTIMIZE AND STANDARDIZE IN VITRO METHODS TO MAKE THEM SUITABLE FOR INDUSTRY AND REGULATORY NEEDS. MANY OF THESE EFFORTS ARE IN COLLABORATION WITH STAKEHOLDERS SUCH AS INDUSTRY, GOVERNMENT AND NGOS. ADVANCEMENTS ARE SHARED WITH THE SCIENTIFIC COMMUNITY THROUGH PRESENTATIONS AND PUBLICATIONS SO THAT OTHER INDUSTRIES AND REGULATORY SCIENTISTS CAN BENEFIT. IIVS HAS DEVELOPED AND PROMOTED THE USE OF HUMAN PRECISION CUT LUNG SLICES (HPCLS) FOR POTENTIAL REGULATORY APPLICATION AS AN ALTERNATIVE TO USING ANIMALS FOR INHALATION AND RESPIRATORY ENDPOINTS. BASED UPON OUR SUCCESSFUL USE OF HPCLS IN IN-HOUSE STUDIES, STAKEHOLDERS HAVE INQUIRED WHETHER THEY COULD PROCURE THESE HPCLS TISSUES FOR USE WITHIN THEIR OWN LABORATORIES. IIVS PREPARED AND QUALIFIED HPCLS TISSUES FOR 30 SPONSOR-RUN LABORATORY STUDIES THAT WOULD HAVE OTHERWISE USED ANIMALS.

  Expenses $6,332,999 · Revenue $6,805,283

• EDUCATION AND OUTREACH: IIVS PARTICIPATES IN NUMEROUS TRAINING ACTIVITIES FOR A VARIETY OF STAKEHOLDERS INCLUDING INDUSTRY AND REGULATORY SCIENTISTS. THESE TRAININGS ARE TAILORED FOR THE SPECIFIC AUDIENCE AND GENERALLY INCLUDE LECTURES, HANDS-ON DEMONSTRATIONS AND DATA INTERPRETATION. TWO MAJOR PROGRAMS IN WHICH IIVS PARTICIPATES ARE THE PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE NURA TRAINING AND THE ANIMAL FREE SAFETY ASSESSMENT COLLABORATION COORDINATED BY HUMANE SOCIETY INTERNATIONAL. IIVS SCIENTISTS WERE INVITED TO PARTICIPATE IN EXPERT PANELS CONVENED BY THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT (OECD) WHICH HARMONIZES IN VITRO TESTING APPROACHES FOR THE WORLDWIDE SCIENTIFIC COMMUNITY. THESE PANELS DISCUSSED NEW METHODS FOR GENETIC TOXICOLOGY, SKIN SENSITIZATION, EYE IRRITATION AND SKIN CORROSION. IIVS IS LEADING EFFORTS WITH INDUSTRY CONSORTIA AND 2 DIVISIONS OF THE U.S. FEDERAL DRUG ADMINISTRATION TO APPLY NON-ANIMAL METHODS FOR SPECIFIC ENDPOINTS. IIVS IS ALSO INVOLVED IN EFFORTS TO SUPPORT THE U.S. ENVIRONMENTAL PROTECTION AGENCY'S GOAL TO REDUCE RELIANCE ON ANIMAL MODELS. IIVS STAFF HOLD BOARD POSITIONS WITHIN SOCIETIES THAT HAVE THE MISSION TO WORK COLLABORATIVELY TO INCREASE THE USE AND ACCEPTANCE OF ALTERNATIVE METHODS, SUCH AS THE AMERICAN SOCIETY FOR CELLULAR AND COMPUTATIONAL TOXICOLOGY, THE EUROPEAN SOCIETY OF TOXICOLOGY IN VITRO, THE U.S. SOCIETY OF TOXICOLOGY AND THE CHINESE SOCIETY OF TOXICOLOGY.

  Expenses $1,066,858 · Revenue $263,773

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2025

  Revenue

  $7,901,249

  Expenses

  $7,883,164

  Contributions

  $793,498

  Grants paid

  $0

• 2024

  Revenue

  $7,953,184

  Expenses

  $7,935,798

  Contributions

  $841,058

  Grants paid

  $0

• 2023

  Revenue

  $6,877,981

  Expenses

  $7,165,636

  Contributions

  $1,057,602

  Grants paid

  $0

• 2022

  Revenue

  $6,860,766

  Expenses

  $6,922,486

  Contributions

  $1,077,048

  Grants paid

  $500

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $6,503,470

  Expenses

  $6,070,350

  Assets (EOY)

  $4,102,375

• 2020 · 990

  Revenue

  $5,879,153

  Expenses

  $5,698,595

  Assets (EOY)

  $4,281,216

• 2019 · 990

  Revenue

  $5,519,690

  Expenses

  $5,897,856

  Assets (EOY)

  $3,490,495

• 2018 · 990

  Revenue

  $5,484,946

  Expenses

  $5,192,081

  Assets (EOY)

  $2,966,766

• 2017 · 990

  Revenue

  $4,450,537

  Expenses

  $4,525,308

  Assets (EOY)

  $2,686,320

• 2016 · 990

  Revenue

  $4,398,140

  Expenses

  $4,632,356

  Assets (EOY)

  $2,443,012

• 2015 · 990

  Revenue

  $3,955,985

  Expenses

  $4,220,450

  Assets (EOY)

  $2,717,439

• 2014 · 990

  Revenue

  $4,237,425

  Expenses

  $4,172,709

  Assets (EOY)

  $2,996,435

• 2013 · 990

  Revenue

  $3,935,387

  Expenses

  $3,400,201

  Assets (EOY)

  $2,881,382

• 2012 · 990

  Revenue

  — not reported

  Expenses

  $3,144,533

  Assets (EOY)

  $2,310,598

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.

Grants received

• ALTERNATIVES FOR RESEARCH AND DEVELOPMENT FOUNDATION

  $27,500

  2025 · SUPPORT OF IIVS EDUCATION AND OUTREACH PROGRAM

• PEOPLE FOR THE ETHICAL TREATMENT OF ANIMALS INC

  $12,800

  2022 · ANIMAL PROTECTION

• ALTERNATIVES FOR RESEARCH AND DEVELOPMENT FOUNDATION

  $12,500

  2022 · DESIGNATED GRANTEE FOR CAVE AWARD TO DR. DANIEL BAGLEY AND EVENT SPONSORSHIP

• ALTERNATIVES FOR RESEARCH AND DEVELOPMENT FOUNDATION

  $10,000

  2023 · SUPPORT OF IIVS EDUCATION AND OUTREACH PROGRAMS

Other IRS files